Hopital Maissoneuve-Rosemont

Montreal, Quebec H1T2M4

0 studies enrolling now · 1 studies all time

What they study most

Her2 Negative Breast Cancer Patients

Studies at this site

• Trial of Exemestane +/- MM-121 in Postmenopausal Women With Locally Advanced or Metastatic Estrogen Receptor Positive and/or Progesterone Receptor Positive Her2 Negative Breast Cancer — Completed